Open Access Open Access  Restricted Access Subscription Access

Frequency of the Mitochondrial A1555G Mutation in Iranian Patients with Non-syndromic Hearing Impairment


Affiliations
1 Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran-14115-111, Iran, Islamic Republic of
2 Cellular and Molecular Research Center, Shahrekord University of Medical Sciences. Shahrekord, Iran, Islamic Republic of
 

Mitochondrial 12S rRNA gene mutations account for non-syndromic hearing impairment (NSHI). The A1555G substitution is the most common mitochondrial DNA mutation and is associated with both aminoglycoside-induced HI and NSHI. Its frequency is variable among populations of different ethnic background. The purpose of the present survey was to determine the frequency of the A1555G mutation in the Iranian probands with NSHI. We have screened 152 unrelated Iranian probands with NSHI with childhood onset and 548 normal hearing controls for the occurrence of the A1555G mutation using PCR-RFLP method. Totally, 2 patients carrying the homoplasmic A1555G mutation were identified with a total frequency of 1.3% in Iran. Mutation A1555G had a variable frequency among subpopulations of different ethnic origins in Iran: Azeri Turkish (4.16%), Lure (0.0%), Fars (0.0%) and Bushehri (2.86%). The A1555G mutation was not found in any member of the controls. Our study shows that the frequency of the A1555G mutation in Azeri Turkish and Bushehri hearing impaired patients is compatible with that reported for Caucasian populations.

Keywords

A1555G, Non-syndromic Hearing Impairment, Iran, mtDNA
User

  • Abe S, Usami S, Shinkawa H, Weston MD, Overbeck LD, Hoover DM, Kenyon JB, Horai S and Kimberling WJ, (1998) “Phylogenetic analysis of mitochondrial DNA in Japanese pedigrees of sensorineural hearing loss associated with the A1555G mutation.” Eur. J. Hum. Genet. 6(6), 563-569.
  • Abreu-Silva RS, Lezirovitz K, Braga MC, Spinelli M, Pirana S, Della-Rosa VA, Otto PA and Mingroni-Netto RC, (2006) “Prevalence of the A1555G (12S rRNA) and tRNASer (UCN) mitochondrial mutations in hearing-impaired Brazilian patients.” Braz. J. Med. Biol. Res. 39(2), 219-226.
  • Bae JW, Lee KY, Choi SY, Lee SH, Park HJ and Kim UK, (2008) “Molecular analysis of mitochondrial gene mutations in Korean patients with nonsyndromic hearing loss.” Int. J. Mol. Med. 22(2), 175-180.
  • Chaleshtori MH, Farrokhi E, Shahrani M, Kheiri S, Dolati M, Rad LH, Pour-Jafari H, Samani KG, Chaleshtori KS and Crosby AH, (2007) “High carrier frequency of the GJB2 mutation (35delG) in the north of Iran.” Intl. J. Pediatr Otorhinolaryngol. 71(6), 863-867.
  • Estivill X, Govea N, Barcelo E, Badenas C, Romero E, Moral L, Scozzri R, D’Urbano L, Zeviani M and Torroni A, (1998) “Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides.” Am. J. Hum. Genet. 62(1), 27-35.
  • Finsterer J and Fellinger J, (2005) “Nuclear and mitochondrial genes mutated in nonsyndromic impaired hearing.” Int. J. Pediatr Otorhinolaryngol. 69(5), 621-647.
  • Grimberg J, Nawoschik S, Belluscio L, McKee R, Turck A and Eisenberg A 1989 “A simple and efficient non-organic procedure for the isolation of genomic DNA from blood.” Nucleic Acids Res. 17(20), 83-90.
  • Guan MX 2004 “Molecular pathogenetic mechanism of maternally inherited deafness.” Ann. N. Y. Acad. Sci. 1011, 259-271.
  • Hashemzadeh Chaleshtori M, Farhud DD and Patton MA, (2007) “Familial and sporadic GJB2-related deafness in Iran: Review of gene mutations.” Iran. J. Publ. Health. 36, 1-14.
  • Jacobs HT, Hutchin TP, Kappi T, Gillies G, Minkkinen K, Walker J, Thompson K, Rovio AT, Carella M, Melchionda S, Zelante L, Gasparini P, Pyykko I, Shah ZH, Zeviani M and Mueller RF (2005), “Mitochondrial DNA mutations in Patients with postlingual, nonsyndromic hearing impairment.” Eur. J. Hum. Genet. 13(1), 26-33.
  • Kokotas H, Grigoriadou M, Korres GS, Ferekidou E, Papadopoulou E, Neou P, Giannoulia-Karantana A, Kandiloros D, Korres S and Petersen MB, (2009) “The A1555G mitochondrial DNA mutation in Greek patients with non-syndromic, sensorineural hearing loss.” Biochem. Biophys. Res. Commun. 390(3), 755-757.
  • Kokotas H, Petersen MB and Willems PJ, (2007) “Mitochondrial deafness.” Clin. Genet. 71(5), 379-391.
  • Konings A, Van Camp G, Goethals A, Van Eyken E, Vandevelde A, Ben Azza J, Peeters N, Wuyts W, Smeets H and Van Laer L, (2008) “Mutation analysis of mitochondrial DNA 12SrRNA and tRNASer(UCN) genes.” in Non-syndromic hearing loss patients. Mitochondrion. 8(5-6), 377-382.
  • Kupka S, Toth T, Wrobel M, Zeissler U, Szyfter W, Szyfter K, Niedzielska G, Bal J, Zenner HP, Sziklai I, Blin N and Pfister M 2002 ‘Mutation A1555G in the 12S rRNA gene and its epidemiological importance in German, Hungarian, and Polish patients.” Hum. Mutat. 19(3), 308-309.
  • Li R, Greinwald JH, Jr, Yang L, Choo DI, Wenstrup RJ and Guan MX, (2004a) “Molecular analysis of the mitochondrial 12S rRNA and tRNASer(UCN) genes in Paediatric subjects with non-syndromic hearing loss.” J. Med. Genet. 41(8), 615-620.
  • Li R, Xing G, Yan M, Cao X, Liu XZ, Bu X and Guan MX, (2004b) “Cosegregation of C-insertion at position 961 with the A1555G mutation of the mitochondrial 12S rRNA gene in a large Chinese family with maternally inherited hearing loss.” Am. J. Med. Genet. A. 124A(2), 113-117.
  • Li Z, Li R, Chen J, Liao Z, Zhu Y, Qian Y, Xiong S, Heman-Ackah S, Wu J, Choo DI and Guan MX, (2005) “Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing loss.” Hum. Genet. 117(1), 9-15.
  • Mahdieh N, Rabbani B, Wiley S, Akbari MT and Zeinali S, (2010) “Genetic causes of nonsyndromic hearing loss in Iran in comparison with other populations.” J. Hum. Genet. 55(10), 639-648.
  • Malik SG, Pieter N, Sudoyo H, Kadir A and Marzuki S, (2003) “Prevalence of the mitochondrial DNA A1555G mutation in sensorineural deafness patients in island Southeast Asia.” J. Hum. Genet. 48(9), 480-483.
  • Marazita ML, Ploughman LM, Rawlings B, Remington E, Arnos KS and Nance WE, (1993) “Genetic epidemiological studies of early-onset deafness in The U.S. school-age population.” Am. J. Med. Genet. 46(5), 486-491.
  • Mkaouar-Rebai E, Tlili A, Masmoudi S, Charfeddine I and Fakhfakh F, (2008) “New polymorphic mtDNA restriction site in the 12S rRNA gene detected in Tunisian patients with non-syndromic hearing loss.” Biochem. Biophys. Res. Commun. 369(3), 849-852.
  • Morton CC and Nance WE, (2006) “Newborn hearing screening--a silent revolution.” N. Engl. J. Med. 354(20), 2151-2164.
  • Nahili H, Charif M, Boulouiz R, Bounaceur S, Benrahma H, Abidi O, Chafik A, Rouba H, Kandil M and Barakat A, (2010) “Prevalence of the mitochondrial A 1555G mutation in Moroccan patients with non-syndromic hearing loss.” Intl. J. Pediatr. Otorhinolaryngol. 74(9), 1071-1074.
  • Najmabadi H, Nishimura C, Kahrizi K, Riazalhosseini Y, Malekpour M, Daneshi A, Farhadi M, Mohseni M, Mahdieh N, Ebrahimi A, Bazazzadegan N, Naghavi A, Avenarius M, Arzhangi S and Smith RJ, (2005) “GJB2 mutations: passage through Iran.” Am. J. Med. Genet. A 133A(2), 132-7.
  • Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Arnos KS, Cortopassi GA, Jaber L and Rotter JI, (1993) “Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness.” Nat. Genet. 4(3), 289-94.
  • Samanich J, Lowes C, Burk R, Shanske S, Lu J, Shanske A and Morrow BE, (2007) “Mutations in GJB2, GJB6, and mitochondrial DNA are rare in African American and Caribbean Hispanic individuals with hearing impairment.” Am. J. Med. Genet. A. 143A(8), 830-838.
  • Tabatabaiefar MA, Alasti F, Montazer Zohour M, Shariati L, Farrokhi E, Farhud DD, Camp GV, Noori-Daloii MR and Chaleshtori MH, (2011) “Genetic linkage Analysis of 15 DFNB Loci in A group of Iranian families with Autosomal recessive hearing loss.” Iran. J. Pub. Health. 40(2), 34-48.
  • Tekin M, Duman T, Bogoclu G, Incesulu A, Comak E, Fitoz S, Yilmaz E, Ilhan I and Akar N, (2003) “Frequency of mtDNA A1555G and A7445G mutations among children with prelingual deafness in Turkey.” Eur. J. Pediatr. 162(3), 154-158.
  • Usami S, Abe S, Akita J, Namba A, Shinkawa H, Ishii M, Iwasaki S, Hoshino T, Ito J, Doi K, Kubo T, Nakagawa T, Komiyama S, Tono T and Komune S, (2000) “Prevalence of mitochondrial gene mutations among hearing impaired patients.” J. Med. Genet. 37(1), 38-40.

Abstract Views: 471

PDF Views: 112




  • Frequency of the Mitochondrial A1555G Mutation in Iranian Patients with Non-syndromic Hearing Impairment

Abstract Views: 471  |  PDF Views: 112

Authors

M. Montazer Zohour
Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran-14115-111, Iran, Islamic Republic of
M. T. Akbari
Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran-14115-111, Iran, Islamic Republic of
M. Hashemzadeh Chaleshtori
Cellular and Molecular Research Center, Shahrekord University of Medical Sciences. Shahrekord, Iran, Islamic Republic of

Abstract


Mitochondrial 12S rRNA gene mutations account for non-syndromic hearing impairment (NSHI). The A1555G substitution is the most common mitochondrial DNA mutation and is associated with both aminoglycoside-induced HI and NSHI. Its frequency is variable among populations of different ethnic background. The purpose of the present survey was to determine the frequency of the A1555G mutation in the Iranian probands with NSHI. We have screened 152 unrelated Iranian probands with NSHI with childhood onset and 548 normal hearing controls for the occurrence of the A1555G mutation using PCR-RFLP method. Totally, 2 patients carrying the homoplasmic A1555G mutation were identified with a total frequency of 1.3% in Iran. Mutation A1555G had a variable frequency among subpopulations of different ethnic origins in Iran: Azeri Turkish (4.16%), Lure (0.0%), Fars (0.0%) and Bushehri (2.86%). The A1555G mutation was not found in any member of the controls. Our study shows that the frequency of the A1555G mutation in Azeri Turkish and Bushehri hearing impaired patients is compatible with that reported for Caucasian populations.

Keywords


A1555G, Non-syndromic Hearing Impairment, Iran, mtDNA

References





DOI: https://doi.org/10.17485/ijst%2F2012%2Fv5i10%2F30916